Vikram Karnani

Vikram Karnani

Chief Executive Officer at COLLEGIUM PHARMACEUTICAL, INC.

Net worth: 1 M $ as of 2026-05-30

51 year
Health Technology
Consumer Services

Profile

Vikram Karnani is President, Chief Executive Officer & Director at Collegium Pharmaceutical, Inc. since 2024.
Mr. Karnani is Independent Director at Dyne Therapeutics, Inc. starting in 2025.
Former roles include VP-Therapeutics & Cell Therapy Business at Fresenius Kabi USA LLC from 2011 to 2014, Chief Commercial Officer & Executive VP at Horizon Therapeutics Ltd. (Ireland) from 2018 to 2020, and President-Commercial Operations & Medical Affairs at Amgen, Inc. Education includes graduate studies at Case Western Reserve University, undergraduate studies at the University of Mumbai, and an MBA from Kellogg School of Management.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-03-30 39,121 ( 0.12% ) 1 M $ 2026-05-30
2026-03-31 0 ( -.--% ) - $ 2026-05-30

Vikram Karnani active positions

CompaniesPositionStart
COLLEGIUM PHARMACEUTICAL, INC. Chief Executive Officer 2024-11-11
DYNE THERAPEUTICS, INC. Director/Board Member 2025-12-21

Former positions of Vikram Karnani

CompaniesPositionEnd
HORIZON THERAPEUTICS PUBLIC LIMITED COMPANY Chief Tech/Sci/R&D Officer 2023-10-31
Corporate Officer/Principal 2014-07-31
AMGEN INC. Chief Tech/Sci/R&D Officer -
See the detail of Vikram Karnani's experience

Training of Vikram Karnani

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

37

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies8

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Consumer Services

Health Technology

  1. Stock Market
  2. Insiders
  3. Vikram Karnani
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!